Last reviewed · How we verify
NCT03647319
Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Post-stroke Cognitive Impairment
NA trial testing High-frequency rTMS on left DLPFC+anodal tDCS on right DLPFC in Post-stroke Cognitive Impairment in 29 participants. Completed in 10 November 2016.
10 November 2016
Quick facts
| Lead sponsor | Samsung Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 29 |
| Start date | 11 April 2013 |
| Primary completion | 10 November 2016 |
| Estimated completion | 10 November 2016 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- High-frequency rTMS on left DLPFC+anodal tDCS on right DLPFC
- High-frequency rTMS on left DLPFC+cathodal tDCS on right DLPFC
- High-frequency rTMS on left DLPFC+sham tDCS on right DLPFC
Conditions studied
- Post-stroke Cognitive Impairment — all drugs for Post-stroke Cognitive Impairment →
Sponsor
Samsung Medical Center
Who can join
Eligibility, any sex, with Post-stroke Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) has been used for the modulation of post-stroke cognitive impairment patients' cognitive function by altering the cortical excitability. Recently, more challenging approaches, such as stimulation of two or more sites or use of dual modality have been studied in stroke patients. In this study, simultaneous stimulation using both facilitatory rTMS (10Hz) and anodal or cathodal tDCS (dual-mode stimulation) over bilateral dorsolateral prefrontal cortices (DLPFCs) was investigated to compare its modulatory effects with single facilitatory rTMS stimulation in post-stroke cognitive impairment patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03647319
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High-frequency rTMS on left DLPFC+anodal tDCS on right DLPFC
Trials testing the same drug.
- NCT03647345 — Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Mild Cognitive Impairment · NA · completed
Other recruiting trials for Post-stroke Cognitive Impairment
Currently open trials in the same condition.
- NCT06316557 — HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke · NA · recruiting
- NCT06315231 — Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients · Phase 2 · recruiting
Other Samsung Medical Center trials
Trials by the same sponsor.
- NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
- NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
- NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
- NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
- NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03647319 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
- Last refreshed: 20 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03647319.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing